Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin

Canadian Journal of Plastic Surgery

Volumn 21, Issue 2, 2013, Pages 87-91

  Wilson, Adel Michel ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

5 fluorouracil; Botulinum toxin; Keloids; Scars; Wound healing

Indexed keywords

EID: 84878310109     PISSN: 11952199     EISSN: None     Source Type: Journal    
DOI: 10.1177/229255031302100208     Document Type: Article

References (39)

1. Berman B, Bieley HC. Keloids. J Am Acad Dermatol 1995;33: 117-21.
2. Peacock EE Jr, Madden JW, Trier WC. Biological basis for the treatment of keloids and hypertrophic scars. South Med J 1970;63: 755-83.
3. Mancini RE, Quaife JW. Histogenesis of experimentally produced keloids. J Invest Dermatol 1962;38: 142-57.
4. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: A comprehensive review. Plast Reconstr Surg 1989;84: 827-33.
5. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids and contractures: The cellular and molecular basis of therapy. Surg Clin North Am 1997;77:701-39 .
6. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996;106: 1007-10.
7. Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 1982;13: 819-23.
8. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993;55: 214-9.
9. Uitto J, Perejda AJ, Abergel RP, Chu ML, Ramirez F. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci USA 1985;82: 5935-41.
10. Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985;84: 384-8.
11. McCoy BJ, Cohen IK. Collagenase in keloid biopsies and fibroblasts. Connect Tissue Res 1982;9: 181-5.
12. Russell SB, Trupin KM, Rodriguez Eaton S, Russell JD, Trupin JS. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 1988;85: 587-91.
13. Garner WL. Karmiol S, Rodriguez JL, Smith DJ Jr, Phan SH. Phenotypic differences in cytokine responsiveness of hypertrophic scars versus normal dermal fibroblasts. J Invest Dermatol 1993;101: 875-80.
14. Chin GS, Liu W, Peled Z, et al. Differential expression of transforming growth factor-B receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 2001;108: 423-8.
15. Haisa M, Okochi H, Grotendorst GR. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994;103: 560-6.
16. Larrabee WF Jr, East CA, Jaffe HS, Stephenson C, Peterson KE. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990;116: 1159-64.
17. Cosman B, Wolff M. Correlation of keloid recurrence with completeness of local excision: A negative report. Plast Reconstr Surg 1972;50: 163-6.
18. Marsh DJ, Pacifico MD, Gault DT. Keloids: When excision is the better part of valor. Plast Reconstr Surg 2008;121: 214-5.
19. Page RE, Robertson GA, Pettigrew NM. Microcirculation in hypertrophic burn scars. Burns Incl Therm Inj 1983;10: 64-8.
20. Park TH, Seo SW, Kim JK, Chang CH. Outcomes of surgical excision with pressure therapy using magnets and identification of risk factors for recurrent keloids Plast Reconstr Surg 2011;128: 431-6.
21. Jemec, G. B. Linear atrophy following intralesional steroid injections. J Dermatol Surg Oncol 1988;14: 88-92.
22. Doornbos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys 1990;18: 833-9.
23. Ogawa R, Yoshitatsu, S, Yoshida K, Miyashita T. Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg 2009;124: 1196-7.
24. Emmanuel R, Etienne B, Patrick P, Michel P, Brigitte D. Perioperative interstitial brachytherapy for recurrent keloid scars Plast Reconstr Surg 2009;124: 180-1.
25. Fulto JE Jr. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg 1995;21: 947-55.
26. Dierickx C, Goldman MP, Fitzpatrick RE. Laser treatment of erythematous/hyertrophic and pigmented scars in 26 patients. Plast Reconstr Surg 1995;95: 84-90.
27. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 2006;32: 907-12.
28. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg 2003;111: 1841-52.
29. The Fluorouracil Filtering Surgery Study Group: 3-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 1993;115: 82-8.
30. Lanignan L, Sturmer J, Baez KA, Hitchings RA, Khaw PT. Single intraoperative applications of 5-fluorouracil during filteration. Br J Ophthalmol 1994;78: 33-40.
31. Uppal RS, Khan Kakar S, Talas G, Chapman P, McGrouther DA. The effects of a single dose of 5-fluorouracil on keloid scars: A clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg 2001;108: 1218-24.
32. Fitzpatrick R. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25224-30.
33. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: An open clinical and histopathologic study. J Am Acad Dermatol 2005;52: 474-81.
34. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004;30: 54-60.
35. Wilson AM. Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg 2006;117: 1758-66.
36. Zhibo X, Miaobo Z, Intralesional botulinum toxin type A injection as a new treatment measure for keloids. Plast Reconstr Surg 2009;124: 276-7.
37. Wilson AM, McGrouther DA, Eastwood M, Brown RA. The effect of burn blister fluid on fibroblast contraction. Burns 1997;23: 306-12.
38. Wilson A.M. Widening of scars: Foe coaxed into friend? Plast Reconstr Surg 2000;106: 1488-93.
39. Davison SP, Dayan JH, Clemens MW, Sonni S, Wang A, Crane A. Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids. Aesthetic Surg J 2009;29: 40-6.